# Bioprocess Market Watch. Every edition and its open data Bioprocess Market Watch is a monthly report by crida studio built on open data from the EMA, the FDA, ClinicalTrials.gov, Eurostat, ANVISA and the PMDA. It counts medicine approvals, clinical trials with biologics and equipment imports into the EU, and explains what they mean for anyone selling bioprocess equipment or services in Europe. Here are all the editions, newest first, with the data behind each one. [Web version](https://www.crida.studio/en/insights/guides/bioprocess-market-watch/) By David Monje, crida studio · Published 2026-11-06 · Updated 2026-11-06 ## What the Market Watch is and who it is for Each edition goes through the official records of the previous month. Which medicines the EMA authorised and which the FDA approved, how many industry trials with biologics started in Europe, the United States, Asia and Latin America, and how EU imports of equipment under heading 8419.89 are moving. It is written for the people who run marketing or sales at a European supplier of bioprocess equipment or services. These are counts from public sources with the method in plain sight, not a demand forecast. ### How often does Bioprocess Market Watch come out? Every month. Each edition gathers the public data for the previous month and comes out once the sources have published it. ## All editions The first in the list is the newest edition. Each one carries the key figure of the month, the charts, the method and the data as CSV and JSON. - [October 2026. 10 industry biologics trials started in Europe in September 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-10/) - [September 2026. 6 industry biologics trials started in Europe in August 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-09/) - [August 2026. 7 industry biologics trials started in Europe in July 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-08/) - [July 2026. 10 industry biologics trials started in Europe in June 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-07/) - [June 2026. 10 industry biologics trials started in Europe in May 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-06/) - [May 2026. 11 industry biologics trials started in Europe in April 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-05/) - [April 2026. 8 industry biologics trials started in Europe in March 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-04/) - [March 2026. 13 industry biologics trials started in Europe in February 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-03/) - [February 2026. 6 industry biologics trials started in Europe in January 2026](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-02/) - [January 2026. 17 industry biologics trials started in Europe in December 2025](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-01/) ## Where the data comes from Every figure comes from public sources, queried the same way each month. Each edition gives the exact query, the download date and the limits of each source. - EMA, the table of medicines authorised in the EU - FDA, CDER novel drug approvals and CBER biologics licence approvals - FDA, warning letters for good manufacturing practice - ClinicalTrials.gov, industry trials with biologics - Eurostat, EU imports under heading 8419.89 - ANVISA and PMDA, registrations in Brazil and Japan ### Are the Market Watch counts demand for bioprocess equipment? No. They are official records, such as trials that start or medicines that get authorised, and import values from Eurostat. They show where there is activity, but not how much equipment or how many consumables will be bought, or by whom. ## How to use the data The data and the charts are under a CC BY 4.0 licence. You can use them in presentations, reports or articles if you credit crida studio and link to this page or to the edition they come from. A new edition comes out every month, once the sources have published the data for the previous month. This address does not change and the list is always up to date. ### Can I use the Market Watch data? Yes. The data and the charts are under a CC BY 4.0 licence. Credit crida studio and link to this page or to the edition the figures come from. ## Open data - [observatori-bioproces-2026-10.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-10.csv) - [observatori-bioproces-2026-09.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-09.csv) - [observatori-bioproces-2026-08.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-08.csv) - [observatori-bioproces-2026-07.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-07.csv) - [observatori-bioproces-2026-06.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-06.csv) - [observatori-bioproces-2026-05.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-05.csv) - [observatori-bioproces-2026-04.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-04.csv) - [observatori-bioproces-2026-03.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-03.csv) - [observatori-bioproces-2026-02.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-02.csv) - [observatori-bioproces-2026-01.csv](https://www.crida.studio/recursos/dades/observatori-bioproces-2026-01.csv) ## References - [EMA, medicines table](https://www.ema.europa.eu/en/medicines/download-medicine-data) - [FDA, CDER novel drug approvals](https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026) - [FDA, CBER biologics license approvals](https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/2026-biological-license-application-approvals) - [FDA, warning letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) - [ClinicalTrials.gov, API v2](https://clinicaltrials.gov/api/v2/studies) - [Eurostat, Comext DS-045409](https://ec.europa.eu/eurostat/web/international-trade-in-goods/database) - [ANVISA, open medicines data](https://dados.anvisa.gov.br/dados/) - [PMDA, list of approved drugs](https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0002.html) ## The crida perspective We are a marketing, brand and technology studio based in Girona. We bring identity, content and development together so a digital experience makes sense from beginning to end. crida studio, Caldes de Malavella (Girona, Spain). David Monje, founder and director. ## Want this analysis applied to your own products? The Market Watch only uses public data. If you want the same analysis for your products or target markets, get in touch and we will work through it with you in a thirty-minute session. [Book the session](https://www.crida.studio/en/#contact) ## More on web design - [Bioprocess Market Watch. October 2026 edition for European suppliers](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-10/) - [Bioprocess Market Watch. September 2026 edition for European suppliers](https://www.crida.studio/en/insights/guides/bioprocess-market-watch-2026-09/) - [Marketing for biotech, bioprocess and pharma companies](https://www.crida.studio/en/insights/services/biotech-bioprocess-pharma-marketing/) - [Horizon Europe bioprocess projects by country and organisation type](https://www.crida.studio/en/insights/guides/horizon-europe-bioprocess-projects/) - [What European bioprocess equipment makers’ websites look like in 2026](https://www.crida.studio/en/insights/guides/european-bioprocess-manufacturer-websites-2026/)